Blood group incompatibility in kidney transplantation: Definitely time to re-examine!

Medical Journal of Australia

Volumn 187, Issue 5, 2007, Pages 306-308

  Cohney, Shlomo J ^a   Walker, Rowan G ^a   Haeusler, Michael N ^a   Francis, David M ^a   Hogan, Chris J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DACLIZUMAB; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ADULT; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP O; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PREOPERATIVE EVALUATION; SPLENECTOMY; BLOOD; BLOOD GROUP INCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; TREATMENT OUTCOME;

ADULT; BLOOD GROUP INCOMPATIBILITY; CREATININE; HUMANS; KIDNEY TRANSPLANTATION; MALE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 34848860502     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb01250.x     Document Type: Article

References (14)

1. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand 1991-2001. Nephrol Dial Transplant 2002; 17: 2212-2219.
2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
3. Excell L, McDonald S. ANZDATA Registry Report 2004. Adelaide: Australia and New Zealand Dialysis and Transplant Registry, 2004. http://www.anzdata.org.au/anzdata/AnzdataReport/27thReport/files/ ContentsandSummary.pdf (accessed Jul 2007).
4. Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 1955; 34: 327-382.
5. Alexandre GP. From ABO-incompatible human kidney transplantation to xenotransplantation. Xenotransplantation 2004; 11: 233-236.
6. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096.
7. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315-1322.
8. Tydén G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145-148.
9. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971-977.
10. Gloor JM, Lager DJ, Fidler ME, et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572-1577.
11. Mackie FE, Tiller DJ. ABO incompatible renal transplantation: a chance to reexamine? Aust N Z J Med 1996; 26: 824-826.
12. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-2575.
13. Tydén G, Kumlien G, Genberg H, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006; 13: 105-107.
14. Cass A, Chadban S, Craig J, et al. The economic impact of end-stage kidney disease in Australia. Melbourne: Kidney Health Australia, 2006. http://www.kidney.org.au/ LinkClick.aspx?fileticket=OfeNvYrIkpA=&tabid=98&mid=918 (accessed Jul 2007).